Views & Analysis Case study: Ensuring safety by digitally linking prescriptio... Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care.
Views & Analysis ‘Listen to your patients’: the best MS care honoured at QuDo... Best healthcare professionals working in multiple sclerosis (MS) honoured QuDoS awards.
Views & Analysis 5 questions: making Multiple Sclerosis care more patient-cen... Trishna Bharadia, Multiple Sclerosis patient advocate, wants to make MS care more patient-centric.
Views & Analysis Addressing the growing need for better Multiple Sclerosis ca... Jo Sopala of the MS Trust describes the organisation's work in creating better multiple sclerosis care.
Views & Analysis Multiple sclerosis: A patient’s perspective A patient's view of the challenges facing people with multiple sclerosis.
News Outlook blindsided as FDA blocks wet AMD drug once again Shares in Outlook Therapeutics lost more than half their value after the FDA turned down the company's marketing application for its wet AMD therapy.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
